UAB Internal Medicine Residency alumnus and President and CEO of Parkland Hospital, Fred Cerise, M.D., MPH, recently visited campus to deliver a lecture to trainees. Following his talk, he toured the Tinsley Harrison Legacy Wall and shared a heartwarming moment with his nephew, current resident Jack LaForge, M.D. The moment was a powerful reminder of the wall’s significance, which honors the legacy of the program and highlights the importance of passing down values through generations. Thank you, Dr. Cerise, for your continued support and contributions to our next generation of physicians!
L to R: Current Resident Dr. Jack LaForge and UAB Internal Medicine Residency Alumnus Dr. Fred Cerise
Good News for February 21, 2025
Study Reports Incidence of JHR in Syphilis Treatment
In a secondary analysis of a clinical trial, Jodie Dionne, M.D., associate professor in ID, found that 1 in 4 adults treated with benzathine penicillin G, experienced short-lived Jarisch-Herxheimer reaction — a known side effect with symptoms that include muscle aches, chills, and fever. The reaction was linked to higher treatment success rates at six months.
Deshmukh Presents Lung Cancer Research at 2025 IASLC Meeting
Postdoctoral research fellow Sameer Deshmukh, M.D., under the mentorship of Dr. Aakash Desai, received a travel grant from the International Association for the Study of Lung Cancer to present his abstract on the safety outcomes of Tarlatamab —a recently approved drug for extensive-stage small cell lung cancer — at the 2025 Targeted Therapies of Lung Cancer Meeting.
Team at Acton Road Keeps Heart Health Celebrations Going
All month long, we've loved sharing photos of employees celebrating National Heart Health Month at UAB! This week, we're giving a big shoutout to our dedicated team at UAB TKC Heart & Vascular Clinic at Acton Road. Thank you all for championing heart health and raising awareness year-round!
🤗👏 DOM Welcomes ...
We are thrilled to welcome acclaimed microbiologist Professor Luis Liu, Ph.D., to the Division of Hematology and Oncology. His lab is developing ProAgio, a protein drug designed to treat pancreatic, breast, lung, and colon cancer. Welcome to UAB, Dr. Liu!